Cross-Sector entity
Sildenafil is most often covered alongside Viagra, which appears in 4 of these 4 stories. The clearest coverage concentration is regulation: 2 of 4 stories, with the rest divided among 2 other categories. We currently track 4 Cross-Sector stories that mention Sildenafil, all published on March 13, 2026.
4 verified stories tracked
Last mentioned: Mar 13, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Sildenafil is most often covered alongside Viagra, which appears in 4 of these 4 stories. The clearest coverage concentration is regulation: 2 of 4 stories, with the rest divided among 2 other categories. We currently track 4 Cross-Sector stories that mention Sildenafil, all published on March 13, 2026. Each carries 26.5 original sources on average.
Computed from the 4 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Sildenafil. Shared-story counts are live from our verified record — not editorial picks.
Public Recall
Official recall notice issued across national news and health networks.
FDA Notification
Regulators confirm the presence of sildenafil and notify the manufacturer.
Initial Testing
Routine laboratory analysis identifies synthetic compounds in wellness supplement samples.
A nationwide recall has been issued for a wellness supplement after FDA testing revealed the presence of sildenafil, the active ingredient in Viagra. The undeclared pharmaceutical poses significant health risks, particularly to individuals with cardiovascular conditions taking nitrates.
A nationwide recall has been issued for a wellness supplement following the discovery of sildenafil, the active ingredient in the prescription drug Viagra. The presence of this undeclared pharmaceutical poses severe health risks, particularly through potentially fatal interactions with common heart medications.
Source: magic1079.iheart.com · love1011.iheart.com
A widespread recall has been issued for a wellness supplement after testing revealed the presence of Sildenafil, the active pharmaceutical ingredient in Viagra. This discovery poses severe health risks to consumers with underlying conditions and underscores the persistent challenges of regulatory oversight in the online supplement market.
A widespread recall has been issued for a wellness supplement after laboratory testing confirmed the presence of sildenafil, the active pharmaceutical ingredient in Viagra. The discovery highlights critical gaps in the regulation of over-the-counter 'natural' products and poses severe risks to consumers with underlying cardiovascular conditions.
Source: power973.iheart.com · kxic.iheart.com
